Veronique Lecault - Jun 21, 2024 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Signature
Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Jun 21, 2024
Transactions value $
$15,667
Form type
4
Date filed
6/24/2024, 06:38 PM
Previous filing
Jan 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Options Exercise $15.7K +83.3K +4.08% $0.19* 2.12M Jun 21, 2024 Direct
holding ABCL Common Shares 61.6K Jun 21, 2024 By spouse
holding ABCL Common Shares 7.16M Jun 21, 2024 See Footnote F1
holding ABCL Common Shares 274K Jun 21, 2024 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Options Exercise $0 -83.3K -2.13% $0.00 3.83M Jun 21, 2024 Common Shares 83.3K $0.19 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F2 These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F3 The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.